Drug Substance Manufacturing - Mammalian Cell Cultures

Drug Substance Manufacturing - Mammalian Cell Cultures

Products

Information

Around 430,000 L total commercial capacity for cell culture Manufacturing sites around the globe: Biberach/Germany, Vienna/Austria, Fremont, CA/USA and Shanghai/ China- from 2,000 up to 15,000 L bioreactors GMP facilities licensed by EMA, FDA, MHLW and other authorities All analytic capabilities inhouse GMP batch release testing Manufacturing of mAbs, recombinant enzymes, Fab fragments, Fc fusion proteins, TandAb, Ig DART, and further complex biologics like bi- or multispecific mAbs
Distribution Areas
North America (USA, Canada)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)
All categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Contract ManufacturingBiomanufacturingProductsServices
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)

Log in

See all the content and easy-to-use features by logging in or registering!